Atnaujinkite slapukų nuostatas

El. knyga: Therapy Resistance in Prostate Cancer: Mechanisms and Insights

Edited by (Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL, USA)
Kitos knygos pagal šią temą:
Therapy Resistance in Prostate Cancer: Mechanisms and InsightsDidesnis paveikslėlis
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Therapy Resistance in Prostate Cancer: Mechanisms and Insights, Volume 20 highlights the main mechanisms that are responsible for therapy resistance in PCa allowing researchers and clinicians to have a synopsis of current options and therapies that can be proposed to overcome resistance. Understanding the mechanisms responsible for chemotherapy resistance helps researchers all over the world delve deeper into the pathways behind this resistance and potentially discover new therapeutic targets for PCa. Prostate cancer (PCa) is among the most diagnosed cancers in men worldwide, as well as one of the most common causes of cancer-related deaths. Despite the advances in treatment, the disease remains associated with poor survival and resistance to cytotoxic and targeted therapies.

1. Prostate Gland Anatomy and Hormonal Factors Contributing to Cancer Development
2. Pathophysiology and Molecular Aberrations of Castration Resistant Prostate Cancer
3. Role of Tumor Microenvironment in Prostate Cancer Therapy Resistance
4. Androgen Receptor-Dependent Mechanisms Mediating Therapy Resistance in Prostate Cancer
5. Epigenetic Changes Driving Therapy Resistance in Prostate Cancer
6. Role of Cancer Stem Cells in Prostate Cancer Therapy Resistance
7. Resistance to Taxane Chemotherapies in Prostate Cancer
8. Resistance of Prostate Cancer to Topoisomerase Inhibitors
9. Resistance of Prostate Cancer to Kinase Inhibitors
10. Radioresistance Mechanisms in Prostate Cancer
11. Immunotherapeutic Strategies and Immunotherapy Resistance in Prostate Cancer
12. Overcoming Resistance in Prostate Cancer with Targeted and Small Molecule-Based Therapies
13. Novel Treatment Strategies to Overcome Resistance in Prostate Cancer

Dr. Bahmad is a physician scientist with more than 8 years of experience in basic, clinical, and translational research (2014-Present), mainly focusing on prostate, bladder, and brain tumors. His research work concentrates on understanding cancer progression and isolating and therapeutically targeting cancer stem cells in solid tumors (such as prostate cancer among others) which are believed to be responsible for therapy resistance and tumor recurrence. He has so far published more than 100 peer-reviewed papers and book chapters in well-reputable journals mainly related to cancer stem cells and overcoming therapy resistance in various tumors. Dr. Bahmad has an MBA degree in Healthcare Management from West Texas A&M University and is currently pursuing his Pathology Residency at Mount Sinai Medical Center of Florida.
Daugiau apie elektronines knygas Daugiau apie elektronines knygas
Pastovi nuoroda: https://www.kriso.lt/db/97804431603326e.html
Raktažodžiai: